期刊文献+

非去极化肌松药致支气管痉挛的M胆碱受体介导机制 被引量:1

Mechanism of muscarinic receptors in bronchospasm caused by nondepolarizing muscle relaxants
下载PDF
导出
摘要 非去极化肌松药(NDMR)引起支气管痉挛的机制仍未完全清楚,组胺释放并不能很好的解释之。最近研究揭示NDMR很可能通过M胆碱受体介导机制诱发支气管痉挛:在生理条件下,位于气道副交感神经节后纤维上的M2受体兴奋后,可抑制神经肌肉接头处乙酰胆碱的过量释放,抑制副交感神经兴奋(如插管时)引起的支气管收缩。NDMR选择性阻断此M2受体亚型,从而引起支气管痉挛的发生。对此机制的探讨为NDMR新药靶标研究和不良反应的防治提供了极为重要的药理学依据。 The mechanism of the nondepolarizing muscle relaxants (NDMR) caused bronchospasm is still unclear, since it can’t be explained perfectly by histamine release. Recent studies have revealed that NDMR may induce bronchospasm via muscarinic receptor-mediated mechanism. M_2 receptor located at postganglionic, parasympathetic nerve fiber in airway, can inhibit excessive acetylcholine release from neuromuscular junction, attenuate the bronchoconstriction caused by parasympathetic nerve stimulation (eg: intubation). NDMR can block this autoinhibitory M_2 receptor subtype and that results in the increasing risk of bronchospasm. The exploration on this complicated mechanism provides us an important pharmacological basis, which can guide us to search the new NDMR agents and control the adverse reactions.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2005年第5期413-416,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 受体 毒蕈碱 神经肌肉去极化药 支气管痉挛 receptors, muscarinic neuromuscular nondepolarizing agents bronchospasm
  • 相关文献

参考文献11

  • 1LIM R. Rapacuronium: premarket drug evaluation can be very effective for the identification of drug risks [J]. Anesth Analg,2003,96(2) :631-632.
  • 2ONRUST SV, FOSTER RH. Rapacuronium bromide: a review of its use in anaesthetic practice[J]. Drugs, 1999,58(5) :887-918.
  • 3JOOSTE E, KLAFTER F, HIRSHMAN CA, et al. A mechanism for rapacuronium-induced bronchospasm: M2 muscarinic receptor antagonism[J]. Anesthesiology, 2003,98(4) :906-911.
  • 4LEVY JH, PITTS M, THANOPOULOS A, et al. The effects ofrapacuronium on histamine release and hemodynamics in adult patients undergoing general anesthesia[J]. Anesth Analg, 1999,89(2) :290-295.
  • 5COULSON FR, FRYER AD. Muscarinic acetylcholine receptors and airway diseases[J]. Pharmacol Ther, 2003,98 (1) :59-69.
  • 6MATSUI M, GRIFFIN MT, SHEHNAZ D, et al. Increased relaxant action of forskolin and isoproterenol against muscarinic agonistinduced contractions in smooth muscle from M2 receptor knockout mice[J]. J Pharmacol Exp Ther, 2003,305(1) :106-113.
  • 7STENGEL PW, YAMADA M, WESS J, et al. M (3) -receptor knockout mice: muscarinic receptor function in atria, stomach fundus, urinary bladder, and trachea[J]. Am J Physiol Regul Integr Comp Physiol, 2002, 282 (5): R1443-R1449.
  • 8HOU VY, HIRSHMAN CA, EMALA CW. Neuromuscular relaxants as antagonists for M2 and M3 muscarinic receptors[J]. Anesthesiology, 1998,88(3) :744-750.
  • 9CAULFIELD MP, BIRDSALL NJ. International Union of Pharmacology. XⅦ. Classification of muscarinic acetylcholine receptors [J]. Pharmacol Rev, 1998,50(2) :279-290.
  • 10STUTH EA, STUCKE AG, SETLOCK MA. Another possible mechanism for bronchospasm after rapacuronium[J]. Anesthesiology, 2002,96(6) :1528-1529.

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部